AstraZeneca Downsizing R&D

On the 2nd of February 2012 AstraZeneca announced the second wave of downsizing its R&D capabilities.
This has a direct impact on Chemovix AB as the four founders of the company are, or should we say were, employed as scientists at the Pharmaceutical R&D unit (formerly known as Process R&D). The upside of this change is that our collected experience becomes publicly available through the care of Chemovix AB.

 

- Bringing automation to the people!